Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ying-Feng Peng
Erratum To: Phase I Clinical Trial of Vaccination With URLC10-derived Peptide for Patients With Advanced Esophageal Cancer
Esophagus
Gastroenterology
Related publications
Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Correction: A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I Clinical Trial of a Peptide Vaccine Combined With Tegafur-Uracil Plus Leucovorin for Treatment of Advanced or Recurrent Colorectal Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Phase I Clinical Trial of Hepatic Arterial Infusion of Paclitaxel in Patients With Advanced Cancer and Dominant Liver Involvement
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology
Randomized Phase II Trial of Survivin 2B Peptide Vaccination for Patients With HLA-A24-positive Pancreatic Adenocarcinoma
Cancer Science
Cancer Research
Medicine
Oncology
Phase I Study of Temozolomide in Paediatric Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
Outcomes of Phase I Clinical Trials for Patients With Advanced Pancreatic Cancer: Update of the MD Anderson Cancer Center Experience
Oncotarget
Oncology